Hospital Costs of Adverse Events in Patients with Metastatic Colorectal Cancer
نویسندگان
چکیده
منابع مشابه
Hospital Costs of Adverse Events in Patients with Metastatic Colorectal Cancer
Background: Monoclonal antibody treatments for metastatic colorectal cancer (mCRC) have distinct treatment-related safety profiles. This study aimed to elucidate the hospitalisation costs of adverse events (AEs) commonly associated with monoclonal antibodies when administered to patients with mCRC. Methods: This study extracted data for patients newly diagnosed with mCRC from a large US claims ...
متن کاملAdverse events associated with bevacizumab and chemotherapy in older patients with metastatic colorectal cancer.
BACKGROUND The safety of bevacizumab in older mCRC patients is poorly understood. The purpose of this analysis was to determine the prevalence, incidence, and risk factors for treatment-related AEs in older bevacizumab recipients. PATIENTS AND METHODS Patients age ≥65 were identified from SEER-Medicare and categorized by mCRC diagnosis pre and post bevacizumab approval (2001-2003 vs. 2005-200...
متن کاملHospital costs associated with adverse events in gynaecological oncology
44 45 Background and objective: Treatment for gynaecological malignancies is complex and may 46 cause unintended or accidental adverse events (AE). We evaluated the costs of hospitalization 47 associated with those AEs among patients who had an abdominal or laparoscopic procedure 48 for proven or suspected gynaecological cancer at a tertiary gynaecological cancer center in 49 Australia. 50 51 M...
متن کاملHospital costs associated with adverse events in gynecological oncology.
BACKGROUND AND OBJECTIVE Treatment for gynecological malignancies is complex and may cause unintended or accidental adverse events (AE). We evaluated the costs of hospitalization associated with those AEs among patients who had an abdominal or laparoscopic procedure for proven or suspected gynecological cancer at a tertiary gynecological cancer center in Australia. METHODS Data on AEs were pr...
متن کاملAdverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
The epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, plays an important role in the control of cell growth and differentiation. Disruption of its signaling leads to neoplastic cell proliferation, migration, stromal invasion, resistance to apoptosis, and angiogenesis.EGFR is overexpressed in a variety of solid tumors, including colorectal cancer ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cancer Therapy
سال: 2013
ISSN: 2151-1934,2151-1942
DOI: 10.4236/jct.2013.41021